SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-015228
Filing Date
2018-06-07
Accepted
2018-06-07 13:41:26
Documents
7
Period of Report
2018-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20180607.htm 8-K 36176
2 EX-1.1 vktx-ex11_6.htm EX-1.1 269138
3 EX-5.1 vktx-ex51_7.htm EX-5.1 10524
4 EX-99.1 vktx-ex991_22.htm EX-99.1 15259
5 GRAPHIC g201806071712469682469.jpg GRAPHIC 2494
6 GRAPHIC g201806071712480502967.jpg GRAPHIC 4765
7 GRAPHIC g201806071712469932470.jpg GRAPHIC 2494
  Complete submission text file 0001564590-18-015228.txt   346171
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 18885939
SIC: 2834 Pharmaceutical Preparations